Choueiri TK - Search Results

1

Adrenocortical carcinoma: the management of metastatic disease.

Fay AP, Elfiky A, Teló GH, McKay RR, Kaymakcalan M, Nguyen PL, Vaidya A, Ruan DT, Bellmunt J, Choueiri TK. Fay AP, et al. Among authors: choueiri tk. Crit Rev Oncol Hematol. 2014 Nov;92(2):123-32. doi: 10.1016/j.critrevonc.2014.05.009. Epub 2014 Jun 4. Crit Rev Oncol Hematol. 2014. PMID: 24958272 Free PMC article. Review.

2

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.

Choueiri TK, Plantade A, Elson P, Negrier S, Ravaud A, Oudard S, Zhou M, Rini BI, Bukowski RM, Escudier B. Choueiri TK, et al. J Clin Oncol. 2008 Jan 1;26(1):127-31. doi: 10.1200/JCO.2007.13.3223. J Clin Oncol. 2008. PMID: 18165647

3

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.

Choueiri TK, Xie W, D'Amico AV, Ross RW, Hu JC, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK. Choueiri TK, et al. Cancer. 2009 Mar 1;115(5):981-7. doi: 10.1002/cncr.24064. Cancer. 2009. PMID: 19152438 Free PMC article.

4

Optimizing recent advances in metastatic renal cell carcinoma.

Courtney KD, Choueiri TK. Courtney KD, et al. Among authors: choueiri tk. Curr Oncol Rep. 2009 May;11(3):218-26. doi: 10.1007/s11912-009-0031-5. Curr Oncol Rep. 2009. PMID: 19336014 Review.

5

Sunitinib in renal-cell carcinoma: expanded indications.

Choueiri TK, Bellmunt J. Choueiri TK, et al. Lancet Oncol. 2009 Aug;10(8):740. doi: 10.1016/S1470-2045(09)70185-8. Epub 2009 Jul 15. Lancet Oncol. 2009. PMID: 19615941 Review. No abstract available.

6

Recent progress and pitfalls in testing novel agents in castration-resistant prostate cancer.

Bellmunt J, Rosenberg JE, Choueiri TK. Bellmunt J, et al. Among authors: choueiri tk. Eur Urol. 2009 Oct;56(4):606-8. doi: 10.1016/j.eururo.2009.07.015. Epub 2009 Jul 22. Eur Urol. 2009. PMID: 19635642 No abstract available.

7

A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib.

Choueiri TK, Mosquera JM, Hirsch MS. Choueiri TK, et al. Clin Genitourin Cancer. 2009 Oct;7(3):E93-4. doi: 10.3816/CGC.2009.n.031. Clin Genitourin Cancer. 2009. PMID: 19815489

8

Targeted therapies: sunitinib in RCC-expanded access equals expanded benefit?

Choueiri TK, Atkins MB. Choueiri TK, et al. Nat Rev Clin Oncol. 2009 Dec;6(12):679-80. doi: 10.1038/nrclinonc.2009.170. Nat Rev Clin Oncol. 2009. PMID: 19942921

9

Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence.

Nguyen PL, Chen MH, Beard CJ, Suh WW, Choueiri TK, Efstathiou JA, Hoffman KE, Loffredo M, Kantoff PW, D'Amico AV. Nguyen PL, et al. Among authors: choueiri tk. Cancer. 2010 Feb 1;116(3):610-5. doi: 10.1002/cncr.24818. Cancer. 2010. PMID: 19957321 Free article.

10

Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death.

Choueiri TK, Chen MH, D'Amico AV, Sun L, Nguyen PL, Hayes JH, Robertson CN, Walther PJ, Polascik TJ, Albala DM, Moul JW. Choueiri TK, et al. Cancer. 2010 Apr 15;116(8):1887-92. doi: 10.1002/cncr.25013. Cancer. 2010. PMID: 20162710 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

829 results

Search Page

Filters